Nicorette Freshfruit (Nicotine)

Nicotine, the active ingredient in Nicorette Freshfruit, is a nicotine replacement therapy presented as an oral mucosal product for oromucosal use. It helps adults who smoke to manage nicotine withdrawal and supports smoking cessation efforts.

GNH USA supplies Nicorette Freshfruit as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals and clinics worldwide. The company ensures quality manufacturing, regulatory compliance, and reliable global distribution to meet the needs of healthcare providers.

Nicorette Freshfruit is used within the nicotine replacement therapy pathway to aid smoking cessation.

Smoking cessation: reduces cravings and withdrawal symptoms, facilitating transition away from combustible tobacco.

Nicotine replacement therapy can be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Mouth irritation or soreness - Hiccups or throat discomfort - Nausea or mild stomach upset - Headache - Dizziness - Unpleasant taste

Serious or Rare Side Effects: - Cardiovascular events such as hypertension, arrhythmia, or chest pain - Severe allergic reactions including rash, swelling, or anaphylaxis - Persistent vomiting or severe nausea - Seizures - Respiratory depression - Prolonged dependence on nicotine

When using Nicorette Freshfruit, several precautions should be observed to ensure safety.

Assess cardiovascular status: patients with recent myocardial infarction or uncontrolled hypertension should use with caution. Avoid use in non‑smokers: nicotine is addictive and should not be initiated in nicotine‑naïve individuals. Monitor for dependence: prolonged use may lead to continued nicotine dependence. Consider pregnancy and lactation: risk is not well established; discuss with a healthcare professional before use. Store at ambient temperature: keep in the original packaging, protect from moisture and heat.

Nicotine may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Beta‑blockers: nicotine‑induced tachycardia may be masked, complicating monitoring. - CYP2A6 inhibitors: can raise nicotine plasma concentrations, increasing side‑effect risk.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): may enhance dizziness. - Antihypertensive agents: nicotine can reduce their efficacy, requiring blood pressure monitoring. - Alcohol: concurrent use may increase nausea and gastrointestinal discomfort.